Literature DB >> 31307980

Evolution of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae by Acquisition of bla VIM-1-Bearing Plasmid.

Ning Dong1,2, Qiaoling Sun3, Yonglu Huang3, Lingbin Shu3, Lianwei Ye1,2, Rong Zhang4, Sheng Chen5,2.   

Abstract

We report the identification of a carbapenem-resistant, hypervirulent Klebsiella pneumoniae (hvKp) strain which produced the carbapenemase VIM-1. Genomic analysis showed that the strain belonged to sequence type ST23 and serotype K1, a major hvKp clone, and harbored three resistance-encoding plasmids. Among them, a bla VIM-1-bearing plasmid was found to possess a mosaic structure presumably generated by multiple gene mobilization events. This finding indicates that hvKp actively acquires mobile resistance-encoding elements, facilitating simultaneous expression of hypervirulence and carbapenem-resistance.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Klebsiella pneumoniae; VIM; carbapenem resistance; hypervirulence

Mesh:

Substances:

Year:  2019        PMID: 31307980      PMCID: PMC6709456          DOI: 10.1128/AAC.01056-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Characterization of an NDM-19-producing Klebsiella pneumoniae strain harboring 2 resistance plasmids from China.

Authors:  Yao Liu; Hong Zhang; Xinzhuo Zhang; Nan Jiang; Zhikun Zhang; Jinping Zhang; Baoli Zhu; Guangxi Wang; Kelei Zhao; Yingshun Zhou
Journal:  Diagn Microbiol Infect Dis       Date:  2018-11-20       Impact factor: 2.803

Review 2.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.

Authors:  Danxia Gu; Ning Dong; Zhiwei Zheng; Di Lin; Man Huang; Lihua Wang; Edward Wai-Chi Chan; Lingbin Shu; Jiang Yu; Rong Zhang; Sheng Chen
Journal:  Lancet Infect Dis       Date:  2017-08-29       Impact factor: 25.071

Review 4.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

5.  Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.

Authors:  Carsten Struve; Chandler C Roe; Marc Stegger; Steen G Stahlhut; Dennis S Hansen; David M Engelthaler; Paal S Andersen; Elizabeth M Driebe; Paul Keim; Karen A Krogfelt
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

6.  Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity.

Authors:  Won-Hee Lee; Hyun-Il Choi; Sung-Wook Hong; Kwang-Sun Kim; Yong Song Gho; Seong Gyu Jeon
Journal:  Exp Mol Med       Date:  2015-09-11       Impact factor: 8.718

7.  Primary osteomyelitis caused by an NDM-1-producing K. pneumoniae strain of the highly virulent sequence type 23.

Authors:  Fabrice Compain; Alexis Vandenberghe; Marie Gominet; Nathalie Genel; David Lebeaux; Astrid Ramahefasolo; Isabelle Podglajen; Dominique Decré
Journal:  Emerg Microbes Infect       Date:  2017-06-21       Impact factor: 7.163

8.  A Novel IncA/C1 Group Conjugative Plasmid, Encoding VIM-1 Metallo-Beta-Lactamase, Mediates the Acquisition of Carbapenem Resistance in ST104 Klebsiella pneumoniae Isolates from Neonates in the Intensive Care Unit of V. Monaldi Hospital in Naples.

Authors:  Eliana P Esposito; Stefano Gaiarsa; Mariateresa Del Franco; Valeria Crivaro; Mariano Bernardo; Susanna Cuccurullo; Francesca Pennino; Maria Triassi; Piero Marone; Davide Sassera; Raffaele Zarrilli
Journal:  Front Microbiol       Date:  2017-11-03       Impact factor: 5.640

9.  Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations.

Authors:  Margaret M C Lam; Ryan R Wick; Kelly L Wyres; Claire L Gorrie; Louise M Judd; Adam W J Jenney; Sylvain Brisse; Kathryn E Holt
Journal:  Microb Genom       Date:  2018-07-09

10.  Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes.

Authors:  Milena M McLaughlin; M Renee Advincula; Michael Malczynski; Grace Barajas; Chao Qi; Marc H Scheetz
Journal:  BMC Infect Dis       Date:  2014-01-15       Impact factor: 3.090

View more
  5 in total

Review 1.  Epidemiological Characteristics and Formation Mechanisms of Multidrug-Resistant Hypervirulent Klebsiella pneumoniae.

Authors:  Miran Tang; Xin Kong; Jingchen Hao; Jinbo Liu
Journal:  Front Microbiol       Date:  2020-11-20       Impact factor: 5.640

2.  Co-occurrence of Rapid Gene Gain and Loss in an Interhospital Outbreak of Carbapenem-Resistant Hypervirulent ST11-K64 Klebsiella pneumoniae.

Authors:  XiaoTuan Zhang; JingLin Ouyang; WenWen He; Tong Zeng; Bin Liu; Hongtao Jiang; Yunsheng Zhang; Linlin Zhou; Haijian Zhou; Zhuoran Liu; Logen Liu
Journal:  Front Microbiol       Date:  2020-11-12       Impact factor: 5.640

Review 3.  Klebsiella species: Taxonomy, hypervirulence and multidrug resistance.

Authors:  Ning Dong; Xuemei Yang; Edward Wai-Chi Chan; Rong Zhang; Sheng Chen
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

4.  The Role of Plasmid and Resistance Gene Acquisition in the Emergence of ST23 Multi-Drug Resistant, Hypervirulent Klebsiella pneumoniae.

Authors:  Pengcheng Du; Chao Liu; Shuaihua Fan; Stephen Baker; Jun Guo
Journal:  Microbiol Spectr       Date:  2022-03-17

Review 5.  Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae.

Authors:  Yu-Ling Han; Xu-Hui Wen; Wen Zhao; Xi-Shan Cao; Jian-Xun Wen; Jun-Rui Wang; Zhi-De Hu; Wen-Qi Zheng
Journal:  Front Microbiol       Date:  2022-09-12       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.